{"schema_version":"secwatch.filing_event.v1","accession":"0001720420-26-000005","form_type":"8-K","ticker":"IBEX","cik":"0001720420","company_name":"IBEX Ltd","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.998220+00:00","generated_at":"2026-05-16T04:29:34.085326+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IBEX reports record Q2 revenue $164.2M (+17% YoY), raises FY revenue & EBITDA guidance","bullets":["Q2 revenue $164.2M (+16.7% YoY); net income $12.2M; diluted EPS $0.83 (+45% YoY).","Adjusted EBITDA $20.7M (+25.2% YoY); adjusted EPS $0.87 (+46% YoY).","Raises FY2026 revenue guidance to $620-630M (from $605-620M) and adjusted EBITDA to $80-82M (from $78-81M).","HealthTech revenue grew 35.1% YoY; repurchased 78,200 shares for $2.9M during quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001720420-26-000005","json":"https://secwatch.observer/filing/0001720420-26-000005.json","markdown":"https://secwatch.observer/filing/0001720420-26-000005.md","text":"https://secwatch.observer/filing/0001720420-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720420/000172042026000005/0001720420-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720420/000172042026000005/ibex-20260205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:29:34.085326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}